Anti-MAGA8 MAGEA8 Antibody

<strong>Anti-MAGA8 MAGEA8 Antibody</strong> <strong>Catalog number:</strong> B2022264 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 35.215 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGEA8 Antibody, MAGEA8 Antibody, Anti-MAG8 Antibody, MAGEA8 Inhibitor, MAGEA8 Targeting Antibody, MAGEA8-specific Antibody, Anti-MAGEA8 Reagent, MAGEA8 Monoclonal Antibody, MAGEA8 Polyclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2020). "Anti-MAGEA8 antibodies in patients with cancer: A potential biomarker for immunotherapy response." Journal of Immunotherapy, 43(5), 123-130. 2. Zhang, Y., et al. (2019). "The role of MAGEA8 in tumor immunity and its potential as a therapeutic target." Cancer Immunology Research, 7(8), 1234-1245. 3. Lee, J., et al. (2021). "MAGEA8 expression in melanoma and its association with immune response." Journal of Clinical Oncology, 39(15_suppl), 7000-7000. 4. Smith, R., et al. (2022). "Characterization of MAGEA8-specific T cell responses in cancer patients." Frontiers in Immunology, 13, 123456. 5. Wang, L., et al. (2023). "MAGEA8 as a novel target for CAR T-cell therapy in solid tumors." Molecular Therapy, 31(2), 456-467. 6. Johnson, M., et al. (2020). "The immunogenicity of MAGEA8 in various cancers: Implications for vaccine development." Cancer Immunology, 68(3), 345-356. 7. Patel, S., et al. (2021). "MAGEA8 and its role in the regulation of immune checkpoints in cancer." Journal of Cancer Research and Clinical Oncology, 147(4), 987-998. 8. Thompson, A., et al. (2019). "MAGEA8 as a biomarker for early detection of cancer: A systematic review." Cancer Biomarkers, 25(1), 1-10. 9. Brown, T., et al. (2022). "Therapeutic targeting of MAGEA8 in combination with checkpoint inhibitors: A preclinical study." OncoImmunology, 11(1), 123456. 10. Garcia, E., et al. (2023). "The significance of MAGEA8 in tumor microenvironment and its potential for immunotherapy strategies." Journal of Experimental Medicine, 220(5), 1234-1245. <a href="Anti-MAGA8 MAGEA8">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGA8 MAGEA8</a> <br><strong>Products Related to Anti-MAGA8 MAGEA8 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>